Normal Newborn DRG Reimbursement & Medicare Rates

DRG 795 represents routine, uncomplicated inpatient care for a normal newborn and defines the clinical scope for coding and payment. It matters for inpatient reimbursement because it establishes the payment classification for standard postnatal care, affecting hospital billing and resource accounting under Centers for Medicare & Medicaid Services rules.

DRG 795 Overview

DRG 795 covers routine care for a healthy term newborn without significant complications, typically assigned when the infant requires only standard postnatal observation and uncomplicated care. This Diagnosis-Related Group matters for Medicare payment because it defines the inpatient reimbursement for normal newborn hospital stays, influencing hospital billing, resource allocation, and payment recognition for uncomplicated deliveries. Assignment hinges on coded diagnoses and procedures documenting the absence of Major Complication or Comorbidity or Complication or Comorbidity. Reimbursement under this group supports standard newborn care services provided during the admission.

Across payers the reported rates for this DRG range roughly from $230 to $7.1K, with payer medians clustering between about $1.8K and $2.9K. The widest spread is between Cigna’s low-end values and Anthem’s high-end maximum ($230 to $7.1K). See the table and chart below for payer-specific distributions and percentile details.

The CMS 2023 data reflect national Medicare fee-for-service inpatient payments reported under the CMS Provider Utilization and Payment Data program. The table below shows avg_tot_pymt_amt (average total payment), avg_submtd_cvrd_chrg (average submitted covered charges), avg_mdcr_pymt_amt (average Medicare payment amount), and tot_dschrgs (total discharges).

Alaska Benchmarks

Alaska’s DRG 795 payments cluster between about 4.5K and 5.6K across major payers, with Anthem and BCBS at the upper end and Cigna at the lower end. The state range is notably higher than common national medians for this DRG, reflecting elevated regional rates. See the table and chart below for payer-specific percentiles and distribution.

Key Insights for Alaska

Anthem is the highest paying payer in Alaska with a mean of 5.6K, while Cigna is the lowest with a mean of 4.5K.
Alaska’s payer means (range roughly 4.5K–5.6K) sit well above typical national medians for this DRG, indicating materially higher newborn reimbursement in the state.

Early-term and full-term newborn transitional physiology studies: observational and interventional studies examine respiratory adaptation, thermoregulation, feeding initiation, and jaundice surveillance in healthy term and near-term neonates in the immediate postpartum period. These studies enroll infants classified as normal newborns (no congenital anomalies, gestational age ≥37 weeks in many protocols) to define best practices for monitoring frequency, thresholds for intervention (e.g., phototherapy initiation criteria for hyperbilirubinemia), and short-stay discharge protocols. Findings are relevant to clinicians and payers because they inform standardized inpatient care pathways that can reduce unnecessary interventions, length of stay, and readmissions while ensuring safe early discharge decisions.
Comparative effectiveness and quality improvement trials on birthing center and hospital delivery care models: randomized or quasi-experimental research compares outcomes among different delivery and newborn care models (rooming-in versus nursery observation, breastfeeding support bundles, lactation consultant availability, and nurse staffing ratios) for otherwise healthy newborns. These studies focus on patient-centered outcomes such as breastfeeding exclusivity, maternal–infant bonding measures, rates of newborn observation transfers, and early neonatal complications that require escalation of care. Results guide hospitals and payers on which care model investments and protocols yield better clinical outcomes and resource use for the large population captured by the Normal Newborn DRG.
Post-discharge infant outcomes and health services research: cohort and registry studies follow infants initially classified as normal newborns after discharge to measure readmission rates, emergency visits for feeding or jaundice issues, developmental screening uptake, and parental satisfaction. These studies often evaluate predictors of early post-discharge problems (e.g., short hospital stay, inadequate feeding support, or social determinants) and assess the impact of postnatal home visits, telehealth follow-up, or early primary care engagement on utilization and outcomes. This evidence is important for payers and providers to design discharge criteria, outpatient follow-up schedules, and transitional care programs that minimize costly readmissions and support population health for newborns in this DRG.

Alaska Benchmarks

Key Insights for Alaska

Anthem is the highest paying payer in Alaska with a mean of 5.6K, while Cigna is the lowest with a mean of 4.5K.
Alaska’s payer means (range roughly 4.5K–5.6K) sit well above typical national medians for this DRG, indicating materially higher newborn reimbursement in the state.

Early-term and full-term newborn transitional physiology studies: observational and interventional studies examine respiratory adaptation, thermoregulation, feeding initiation, and jaundice surveillance in healthy term and near-term neonates in the immediate postpartum period. These studies enroll infants classified as normal newborns (no congenital anomalies, gestational age ≥37 weeks in many protocols) to define best practices for monitoring frequency, thresholds for intervention (e.g., phototherapy initiation criteria for hyperbilirubinemia), and short-stay discharge protocols. Findings are relevant to clinicians and payers because they inform standardized inpatient care pathways that can reduce unnecessary interventions, length of stay, and readmissions while ensuring safe early discharge decisions.
Comparative effectiveness and quality improvement trials on birthing center and hospital delivery care models: randomized or quasi-experimental research compares outcomes among different delivery and newborn care models (rooming-in versus nursery observation, breastfeeding support bundles, lactation consultant availability, and nurse staffing ratios) for otherwise healthy newborns. These studies focus on patient-centered outcomes such as breastfeeding exclusivity, maternal–infant bonding measures, rates of newborn observation transfers, and early neonatal complications that require escalation of care. Results guide hospitals and payers on which care model investments and protocols yield better clinical outcomes and resource use for the large population captured by the Normal Newborn DRG.
Post-discharge infant outcomes and health services research: cohort and registry studies follow infants initially classified as normal newborns after discharge to measure readmission rates, emergency visits for feeding or jaundice issues, developmental screening uptake, and parental satisfaction. These studies often evaluate predictors of early post-discharge problems (e.g., short hospital stay, inadequate feeding support, or social determinants) and assess the impact of postnatal home visits, telehealth follow-up, or early primary care engagement on utilization and outcomes. This evidence is important for payers and providers to design discharge criteria, outpatient follow-up schedules, and transitional care programs that minimize costly readmissions and support population health for newborns in this DRG.

OpenPayer

Summary & Overview

Normal Newborn: Inpatient Reimbursement Overview

DRG 795 Overview

National Payment Rates

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes